PPM1D and cancer: In combination with DNA damage-inducing chemotherapy or with MDM2 antagonists (such as nutlin-3), WIP1 inhibition promotes cancer cell death or senescence, while healthy cells with basal WIP1 expression are relatively resistant to its inhibition [136].